Hydromorphone Hydrochloride
- Product NDC
- 0641-0121
- Requested package NDC
- 0641-0121-25
- 11-digit product format
- 006410121
- Labeler code
- 0641
- Product ID
- 0641-0121_b58ab10f-f9d0-4cea-966d-9fe9acf49b03
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydromorphone Hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 1972-01-01
- Marketing end
- 0000-00-00
- Substance
- HYDROMORPHONE HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Full Opioid Agonists [MoA], Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0641-0121 | 0641-0121-25 | D | Discontinued by firm | 2026-10-12 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c92985da-a658-b186-e763-2287eda87a86 | Product name | 3 | 20250221 |
| 96c475b3-58c7-b955-d715-0111804a3e50 | Product name | 5 | 20210512 |
| 1dd54659-b775-4fa8-a858-7f0e521fbadc | Product name | 4 | 20200925 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-0121-21 | Hydromorphone Hydrochloride | 1 mL in 1 VIAL | INJECTION | 1 | 9 | |
| 0641-0121-25 | Hydromorphone Hydrochloride | 25 in 1 CARTON | INJECTION | 25 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-0121-21 | ML - Milliliter | 0641-0121 | a50fa085-0e05-4962-b5d7-c99363dc8e0f | 1 | 2012-07-24 |
| 0641-0121-25 | ML - Milliliter | 0641-0121 | fc1ecab4-5b73-4f0c-9061-85ac04bc3bd4 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HYDROMORPHONE HYDROCHLORIDE | ACTIVE INGREDIENT | L960UP2KRW | HYDROMORPHONE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 5 | |
| HYDROMORPHONE | ACTIVE MOIETY | Q812464R06 | HYDROMORPHONE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 5 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | HYDROMORPHONE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 5 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | HYDROMORPHONE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 5 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | HYDROMORPHONE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 5 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | HYDROMORPHONE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 5 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | HYDROMORPHONE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 5 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | HYDROMORPHONE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | b325028e-0722-4c8c-9fdb-ab6fb0dc460c | 2026-03-02 | Warnings, Adverse reactions | 0641-0121-25 0641-0121 00641012125 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1724276 | HYDROmorphone HCl 2 MG in 1 ML Injection | PSN | b325028e-0722-4c8c-9fdb-ab6fb0dc460c | 9 |
| 897745 | HYDROmorphone HCl 2 MG/ML Injectable Solution | PSN | b325028e-0722-4c8c-9fdb-ab6fb0dc460c | 9 |
| 1724276 | 1 ML hydromorphone hydrochloride 2 MG/ML Injection | SCD | b325028e-0722-4c8c-9fdb-ab6fb0dc460c | 9 |
| 897745 | hydromorphone hydrochloride 2 MG/ML Injectable Solution | SCD | b325028e-0722-4c8c-9fdb-ab6fb0dc460c | 9 |
| 1724276 | hydromorphone HCl 2 MG per 1 ML Injection | SY | b325028e-0722-4c8c-9fdb-ab6fb0dc460c | 9 |
| 897745 | hydromorphone HCl 2 MG/ML Injectable Solution | SY | b325028e-0722-4c8c-9fdb-ab6fb0dc460c | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0641-0121-25 | 00641012125 | 25 VIAL in 1 CARTON (0641-0121-25) > 1 mL in 1 VIAL (0641-0121-21) | 25 vial | 1972-01-01 | 0000-00-00 | No | No | Current |